Leadership Overview
Lupin has 10 executives leading key functions including strategy, operations, finance, administration, research, revenue, marketing, human resources, and information technology.
Driven by a commitment to global healthcare excellence, Lupin advances human health through compassionate innovation and the pursuit of accessible pharmaceutical solutions across international markets.
Driven by a commitment to global healthcare excellence, Lupin advances human health through compassionate innovation and the pursuit of accessible pharmaceutical solutions across international markets.
Leadership Roles at Lupin
Ashutosh Inamdar - Chief Executive Officer
Ashutosh Inamdar, the Chief Executive Officer at Lupin, directs the overarching strategic vision and global expansion initiatives for the organization. By aligning research capabilities with market demands, the Chief Executive Officer ensures the delivery of high-quality pharmaceutical products to diverse patient populations. Ashutosh Inamdar maintains rigorous oversight of corporate governance while fostering a culture of innovation that defines the company's competitive edge. This leadership role involves constant collaboration with the Board to refine long-term growth trajectories and operational efficiency. Through the management of complex international supply chains and regulatory landscapes, the Chief Executive Officer secures the firm's position as a leader in the global healthcare sector. Ultimately, the executive drives sustainable value creation by balancing immediate performance targets with the long-term mission of improving patient outcomes through advanced medical science and compassionate care.
Satheesh Sekar - Chief of Staff To the Chief Executive Officer
Satheesh Sekar, the Chief of Staff To the Chief Executive Officer at Lupin, facilitates the execution of strategic priorities by coordinating communication between the executive office and various business units. Overseeing the flow of critical information, the Chief of Staff To the Chief Executive Officer ensures that leadership decisions translate into actionable tasks across the organization. Satheesh Sekar manages high-priority projects that require cross-departmental alignment and executive oversight. This leadership role involves synthesizing complex data to support the decision-making process of the Chief Executive Officer. By streamlining administrative workflows and fostering internal collaboration, the Chief of Staff To the Chief Executive Officer enhances the overall agility of the company. Through the management of key stakeholder relationships, Sekar ensures that the strategic vision remains consistent across all operational levels. The executive plays a vital role in maintaining the operational rhythm necessary for achieving the company's ambitious healthcare goals.
Hitanshu Shah - Chief Financial Officer
Hitanshu Shah, the Chief Financial Officer at Lupin, governs the financial health and capital allocation strategies that fuel the company's research and development pipeline. Managing global fiscal reporting and investor relations, the Chief Financial Officer ensures transparency and compliance across all international jurisdictions. Hitanshu Shah architects robust financial frameworks to support long-term investment in pharmaceutical innovation and market expansion. This leadership role involves close collaboration with the executive team to assess the economic viability of new product launches and strategic acquisitions. By optimizing capital structures and managing liquidity, the Chief Financial Officer secures the resources necessary for sustained growth. Through rigorous financial planning and risk assessment, Shah maintains the fiscal stability required to navigate the volatile healthcare market. The executive provides the analytical foundation for all major business decisions, ensuring that every investment aligns with the core mission of enhancing global health.
Sujal Thakkar - Deputy General Manager - Corporate Finance and Strategy. Executive Director and Global Chief Financial Officer Office
Sujal Thakkar, the Deputy General Manager - Corporate Finance and Strategy. Executive Director and Global Chief Financial Officer Office at Lupin, drives the development of long-term strategic plans and financial modeling for the global enterprise. Overseeing the integration of corporate strategy with financial performance, the Deputy General Manager - Corporate Finance and Strategy. Executive Director and Global Chief Financial Officer Office ensures that resource allocation supports the company's core mission. Sujal Thakkar analyzes market trends to identify growth opportunities and mitigate potential financial risks. This leadership role involves providing the Global Chief Financial Officer with actionable insights derived from detailed performance data. By aligning departmental objectives with the broader corporate strategy, the executive fosters a culture of fiscal responsibility and innovation. Through the management of strategic initiatives, Thakkar ensures that the organization remains competitive in the rapidly evolving pharmaceutical landscape, ultimately supporting the delivery of high-quality healthcare solutions.
Vijay Ghogare - Chief Operating Officer
Vijay Ghogare, the Chief Operating Officer at Lupin, manages the end-to-end manufacturing processes and operational workflows that sustain the company's global pharmaceutical output. Overseeing the integration of advanced production technologies, the Chief Operating Officer optimizes facility performance to meet stringent international quality standards. Vijay Ghogare coordinates cross-functional teams to streamline logistics and enhance supply chain resilience across major regional markets. This leadership role requires constant monitoring of production metrics to ensure alignment with corporate efficiency goals and safety protocols. By refining internal processes, the Chief Operating Officer directly impacts the scalability of the manufacturing division. Through the implementation of lean methodologies, Ghogare reduces operational waste while maintaining the high standards of excellence expected in the healthcare industry. The executive ensures that all manufacturing activities support the broader mission of delivering reliable, life-saving medications to patients worldwide.

Swati Kelkar - Research Scientist & Chief Revenue Officer
Swati Kelkar, the Research Scientist & Chief Revenue Officer at Lupin, bridges the gap between scientific innovation and commercial success by overseeing the revenue generation strategies for new pharmaceutical developments. Managing the transition of research findings into market-ready products, the Research Scientist & Chief Revenue Officer ensures that scientific breakthroughs translate into tangible business growth. Swati Kelkar coordinates with the research teams to prioritize projects with the highest potential for clinical impact and financial return. This leadership role involves analyzing market data to refine pricing and distribution strategies for innovative therapies. By leveraging scientific expertise to inform revenue models, the Research Scientist & Chief Revenue Officer maximizes the commercial viability of the company's portfolio. Through the strategic oversight of product lifecycles, Kelkar ensures that the organization continues to lead in the development of advanced medical treatments, directly contributing to the company's mission of improving patient health.
Supratik Sengupta - Chief Marketing Officer, Lupinlife Consumer Healthcare
Supratik Sengupta, the Chief Marketing Officer, Lupinlife Consumer Healthcare at Lupin, directs the brand strategy and consumer engagement initiatives for the company's healthcare products. Overseeing the development of marketing campaigns that resonate with diverse consumer demographics, the Chief Marketing Officer, Lupinlife Consumer Healthcare ensures that the brand remains synonymous with trust and quality. Supratik Sengupta manages the digital and traditional marketing channels to expand the reach of consumer health solutions across regional markets. This leadership role involves analyzing consumer behavior to tailor product messaging and improve market penetration. By fostering strong relationships with retail partners and consumers, the Chief Marketing Officer, Lupinlife Consumer Healthcare drives brand loyalty and revenue growth. Through the execution of innovative marketing strategies, Sengupta ensures that the company's consumer healthcare offerings effectively address the needs of the public, reinforcing the organization's commitment to accessible and compassionate healthcare solutions.
Shruti Pai - Chief Human Resources Officer
Shruti Pai, the Chief Human Resources Officer at Lupin, manages the talent acquisition, organizational development, and employee engagement strategies that support the company's global workforce. Overseeing the implementation of human capital policies, the Chief Human Resources Officer ensures that the organization attracts and retains the best talent in the pharmaceutical industry. Shruti Pai fosters a culture of inclusivity and professional growth that aligns with the company's core values. This leadership role involves designing training programs that enhance the skills of the workforce, ensuring that employees remain equipped to meet the challenges of a dynamic healthcare environment. By optimizing performance management systems, the Chief Human Resources Officer drives organizational efficiency and employee satisfaction. Through the strategic management of human capital, Pai ensures that the company maintains the expertise and dedication required to achieve its mission of improving global health outcomes through innovation and compassion.
Nagesh Kothari - Chief Revenue Officer, At Lupinlife Consumer Healthcare
Nagesh Kothari, the Chief Revenue Officer, At Lupinlife Consumer Healthcare at Lupin, manages the sales operations and revenue growth strategies for the consumer healthcare division. Overseeing the expansion of distribution networks, the Chief Revenue Officer, At Lupinlife Consumer Healthcare ensures that products reach consumers efficiently across various geographic regions. Nagesh Kothari analyzes sales performance data to identify opportunities for market expansion and revenue optimization. This leadership role involves collaborating with marketing and product teams to align sales strategies with consumer demand. By driving the adoption of consumer health products, the Chief Revenue Officer, At Lupinlife Consumer Healthcare directly contributes to the financial success of the division. Through the management of sales teams and channel partnerships, Kothari ensures that the company's consumer healthcare solutions remain accessible and competitive. The executive focuses on achieving sustainable revenue growth while upholding the company's commitment to providing high-quality healthcare products to the public.
Kiritkumar Dumraliya - Deputy General Manager - Strategic Information Technology Projects (Chief Information Officer Office)
Kiritkumar Dumraliya, the Deputy General Manager - Strategic Information Technology Projects (Chief Information Officer Office) at Lupin, architects the digital infrastructure and technology projects that support the company's global operations. Overseeing the implementation of advanced IT systems, the Deputy General Manager - Strategic Information Technology Projects (Chief Information Officer Office) ensures that data management and cybersecurity protocols meet the highest industry standards. Kiritkumar Dumraliya coordinates with the Chief Information Officer to align technology investments with the company's strategic goals. This leadership role involves managing complex IT projects that enhance operational efficiency and data-driven decision-making across all departments. By integrating innovative digital solutions, the executive supports the company's ability to respond to market changes and maintain a competitive edge. Through the management of strategic IT initiatives, Dumraliya ensures that the organization's technological foundation remains robust, secure, and capable of supporting the company's mission of delivering advanced healthcare solutions.
Explore Leadership Teams in Manufacturing
Synokem Pharmaceuticals Ltd is a rising pharmaceutical organization established in 1983, specializing in contract manufacturing, ethical marketing, exports, and institutional supplies. The company aims to provide quality pharmaceutical products that are affordable to all sections of society, with a vision to become a world-class manufacturer. Synokem is committed to enhancing its market share through strategic alliances and collaborations, particularly in the international business sector. With a focus on research and development, the company is dedicated to achieving significant growth and establishing itself as an industry leader.
Company Leadership PS
SA
AK
RM
Established in 1978 and headquartered in London, Hikma Pharmaceuticals is a multinational pharmaceutical company that manufactures branded and non-branded generic and in-licensed pharmaceutical products.
Company Leadership
CS
TD
AK
Abdi Ibrahim provides pharmaceutical services to the healthcare sector that are beneficial in maintaining people's health. Abdi Ibrahim was founded in 1912 and is based in Istanbul, Turkey.
Company Leadership GO
MÇ
OneSource Specialty Pharma Limited is a multimodal specialty pharmaceutical contract development and manufacturing organization headquartered in Bengaluru, India. Formed through the merger of three CDMO businesses within the Strides Group, specifically Stelis Biopharma's Biologics CDMO, SteriScience's Complex Injectables, and Strides' Soft Gelatin businesses, OneSource was officially launched at CPHI Milan in 2024. The company operates five state-of-the-art manufacturing facilities in Bengaluru, all approved by major regulatory bodies including the US FDA, European Union authorities, and the Therapeutic Goods Administration. With over 30 years of manufacturing and quality excellence, OneSource employs more than 1,200 professionals, including over 200 techno-commercial experts, and serves more than 50 global pharmaceutical and biotechnology clients. The company specializes in end-to-end capabilities across multiple technology platforms and therapeutic modalities, including biologics drug substance and drug product manufacturing, drug-device combinations such as prefilled syringes and autoinjectors, complex sterile injectables, and soft gelatin capsules. OneSource has the capacity to produce over 100 million injectable doses and 2.4 billion soft gelatin capsules annually, with its flagship Bangalore site being one of the few facilities globally capable of manufacturing both biologics drug substance and drug product on the same premises. The company holds 35 approved Abbreviated New Drug Applications and has 19 commercialized drug products in the United States. Led by CEO Neeraj Sharma and Chief Quality Officer Bernhard Thurnbauer, OneSource is positioned to capitalize on growing demand for GLP-1 drug-device combinations and supply chain diversification driven by the BIOSECURE Act, projecting 32 percent revenue growth in 2025 with sales expected to reach 400 million dollars by 2028.
Company Leadership NS
SN
BM
